CELGENE EUROPE LIMITED
Get an alert when CELGENE EUROPE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-27 (in 9mo)
Last made up 2026-02-13
Watchouts
None on the register
Cash
£4M
-44.5% vs 2023
Net assets
£28M
+0.9% vs 2023
Employees
76
+2.7% vs 2023
Profit before tax
£3M
-10.9% vs 2023
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £15,985,584 | £16,268,480 | |
| Operating profit | £1,494,813 | £1,479,214 | |
| Profit before tax | £3,419,069 | £3,047,766 | |
| Net profit | £3,320,771 | £2,818,462 | |
| Cash | £7,201,432 | £3,993,661 | |
| Total assets less current liabilities | — | — | |
| Net assets | £28,062,689 | £28,322,090 | |
| Equity | £28,062,689 | £28,322,090 | |
| Average employees | 74 | 76 | |
| Wages | £9,114,450 | £10,285,413 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 9.4% | 9.1% | |
| Net margin | 20.8% | 17.3% | |
| Current ratio | 1.78x | 2.24x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have made an assessment covering a period of 12 months from the date of approval of these financial statements which indicate that, taking account of reasonably possible downsides, the company will have sufficient funds, through support from its ultimate parent company, Bristol Myers Squibb Company, to meet its liabilities as they fall due for that period.”
Significant events
- “There have been no significant events since the year end that require adjustments or disclosure in the financial statements.”
- “There are no events to report after the statement of financial position date.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 27 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FALLONE, Amy Eirlys Polizzano | Director | 2024-06-20 | Jul 1986 | American |
| OLIVER, Guy Edward | Director | 2024-03-11 | May 1978 | New Zealander,British |
| ONG, Annie | Director | 2023-11-08 | Apr 1974 | Malaysian |
Show 27 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARER, Sol Joseph | Secretary | 2002-02-13 | 2006-10-20 |
| CITCO MANAGEMENT (UK) LIMITED | Corporate Secretary | 2011-02-03 | 2025-06-15 |
| COMAT REGISTRARS LIMITED | Corporate Secretary | 2006-10-20 | 2011-02-02 |
| COMPANY LAW CONSULTANTS LIMITED | Corporate Secretary | 2003-09-18 | 2006-08-15 |
| ALLES, Mark John | Director | 2016-06-20 | 2018-03-26 |
| BARER, Sol Joseph | Director | 2002-02-13 | 2006-10-20 |
| BAZARKO, Daniel Adrian | Director | 2012-02-20 | 2013-06-03 |
| BILLER, Jonathan Prim | Director | 2012-02-20 | 2019-02-28 |
| BROUWER, Aart | Director | 2006-10-20 | 2011-05-16 |
| COLOWICK, Alan Burton | Director | 2012-02-20 | 2014-09-15 |
| COOKE, John Scott | Director | 2021-07-20 | 2023-11-08 |
| FLANIGAN III, Patrick Eugene | Director | 2019-02-28 | 2019-11-26 |
| HOCH, Lynelle B. | Director | 2020-04-30 | 2021-07-20 |
| HUGIN, Robert | Director | 2006-10-20 | 2016-06-20 |
| JABLONSKI, Kimberly Mccutcheon | Director | 2022-01-19 | 2024-06-20 |
| JACKSON, John Wyant | Director | 2002-02-13 | 2006-10-20 |
| JASKO, Stephen | Director | 2006-10-20 | 2008-09-05 |
| KELLY, Katherine Reynolds | Director | 2019-11-26 | 2021-09-17 |
| MAHATME, Sandesh | Director | 2006-10-20 | 2012-02-20 |
| OEHEN, Jurg | Director | 2006-10-20 | 2019-02-28 |
| PATSI, Tuomo Tapani | Director | 2014-09-15 | 2020-08-03 |
| PELLIER, Anne Patricia Janine | Director | 2013-06-03 | 2019-02-28 |
| PIGNOLET, David Walter | Director | 2019-02-28 | 2022-01-19 |
| SERRY, Nakisa | Director | 2006-10-20 | 2020-08-03 |
| VAN HOEK, Andre Laurent Elisabeth Maria | Director | 2008-09-05 | 2012-02-20 |
| VAN HOLLE, Phiippe Marie Marcel Joseph | Director | 2006-10-20 | 2012-02-20 |
| VARGAS QUINTAS CAMPOS, Teresa Maria | Director | 2020-04-30 | 2022-10-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bristol-Myers Squibb Company | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-11-20 | Active |
| Celgene Corporation | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-11-20 |
Filing timeline
Last 20 of 155 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-29 | AA | accounts | Accounts with accounts type full | |
| 2025-06-30 | AD02 | address | Change sail address company with old address new address | |
| 2025-06-30 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-02-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-10 | AA | accounts | Accounts with accounts type full | |
| 2024-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-27 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2023-11-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-17 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-07 | AA | accounts | Accounts with accounts type full | |
| 2023-07-06 | CH01 | officers | Change person director company with change date | |
| 2023-07-03 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-02-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-03 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-23 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-09-23 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+1.8%
£15,985,584 £16,268,480
-
Cash
-44.5%
£7,201,432 £3,993,661
-
Net assets
+0.9%
£28,062,689 £28,322,090
-
Employees
+2.7%
74 76
-
Operating profit
-1%
£1,494,813 £1,479,214
-
Profit before tax
-10.9%
£3,419,069 £3,047,766
-
Wages
+12.8%
£9,114,450 £10,285,413
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers